Compare Stocks: PRTC, ONT, OXB, and SLN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ONT Montrose Environmental Group	$21.03 +4.0%	$18.73	$14.13 ▼ $32.00	$730.73M	1.67	451,149 shs	367,600 shs
PRTC PureTech Health	$17.42	$17.42	$14.50 ▼ $19.92	$424.04M	1.15	18,480 shs	N/A
SLN Silence Therapeutics	$10.49 -9.7%	$8.85	$4.19 ▼ $12.19	$548.87M	1.38	495,673 shs	555,365 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ONT Montrose Environmental Group	+3.44%	+6.97%	+2.19%	-4.94%	-5.18%
PRTC PureTech Health	0.00%	0.00%	0.00%	-3.97%	-8.65%
SLN Silence Therapeutics	-9.72%	-4.81%	-0.10%	+47.12%	+70.57%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ONT Montrose Environmental Group	$21.03 +4.0%	$18.73	$14.13 ▼ $32.00	$730.73M	1.67	451,149 shs	367,600 shs
PRTC PureTech Health	$17.42	$17.42	$14.50 ▼ $19.92	$424.04M	1.15	18,480 shs	N/A
SLN Silence Therapeutics	$10.49 -9.7%	$8.85	$4.19 ▼ $12.19	$548.87M	1.38	495,673 shs	555,365 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ONT Montrose Environmental Group	+3.44%	+6.97%	+2.19%	-4.94%	-5.18%
PRTC PureTech Health	0.00%	0.00%	0.00%	-3.97%	-8.65%
SLN Silence Therapeutics	-9.72%	-4.81%	-0.10%	+47.12%	+70.57%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ONT Montrose Environmental Group	2.20	Hold	$23.00	9.37% Upside
PRTC PureTech Health	1.00	Sell	N/A	N/A
SLN Silence Therapeutics	2.83	Moderate Buy	$55.00	424.31% Upside

Current Analyst Ratings Breakdown

Latest PRTC, ONT, OXB, and SLN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/17/2026	SLN Silence Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/13/2026	ONT Montrose Environmental Group	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$24.00 ➝ $22.00
6/24/2026	SLN Silence Therapeutics	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight
6/17/2026	SLN Silence Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$75.00
6/2/2026	ONT Montrose Environmental Group	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
5/29/2026	ONT Montrose Environmental Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
5/18/2026	PRTC PureTech Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (D-)
5/18/2026	ONT Montrose Environmental Group	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$40.00 ➝ $19.00
5/8/2026	ONT Montrose Environmental Group	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$35.00 ➝ $28.00
5/4/2026	ONT Montrose Environmental Group	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell

(Data available from 8/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ONT Montrose Environmental Group	$830.54M	0.92	$1.90 per share	11.04	$12.77 per share	1.65
PRTC PureTech Health	$4.66M	91.01	N/A	N/A	$12.65 per share	1.38
SLN Silence Therapeutics	$560K	884.91	N/A	N/A	$1.32 per share	7.95

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ONT Montrose Environmental Group	-$840K	$0.05	420.68	25.96	1.48	0.71%	5.61%	2.61%	8/5/2026 (Estimated)
PRTC PureTech Health	-$109.74M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	8/27/2026 (Estimated)
SLN Silence Therapeutics	-$88.61M	-$1.59	N/A	N/A	N/A	-8,943.86%	-105.34%	-52.79%	8/6/2026 (Estimated)

Latest PRTC, ONT, OXB, and SLN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/27/2026	H1 2026	PRTC PureTech Health	-$1.16	N/A	N/A	N/A	$24.80 million	N/A
8/6/2026	Q2 2026	SLN Silence Therapeutics	-$0.1387	N/A	N/A	N/A	$1.17 million	N/A
8/5/2026	Q2 2026	ONT Montrose Environmental Group	$0.0774	N/A	N/A	N/A	$179.69 million	N/A
5/8/2026	Q1 2026	SLN Silence Therapeutics	-$0.1850	-$0.32	-$0.1350	-$0.33	$1.26 million	$0.42 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ONT Montrose Environmental Group	N/A	N/A	N/A	N/A	N/A
PRTC PureTech Health	N/A	N/A	N/A	N/A	N/A
SLN Silence Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ONT Montrose Environmental Group	0.76	1.84	1.84
PRTC PureTech Health	N/A	6.59	6.59
SLN Silence Therapeutics	N/A	9.83	9.83

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ONT Montrose Environmental Group	87.87%
PRTC PureTech Health	0.04%
SLN Silence Therapeutics	98.73%

Insider Ownership

Company	Insider Ownership
ONT Montrose Environmental Group	10.40%
PRTC PureTech Health	5.30%
SLN Silence Therapeutics	3.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ONT Montrose Environmental Group	3,500	36.14 million	32.38 million	Optionable
PRTC PureTech Health	100	24.34 million	23.05 million	Not Optionable
SLN Silence Therapeutics	100	47.24 million	45.82 million	Not Optionable

PRTC, ONT, OXB, and SLN Headlines

Recent News About These Companies

Silence Therapeutics (SLN) to Post Earnings on Thursday

July 30 at 4:40 AM | marketbeat.com

ADAR1 Capital Management LLC Buys 148,514 Shares of Silence Therapeutics PLC Sponsored ADR $SLN

July 30 at 3:03 AM | marketbeat.com

Silence Therapeutics (NASDAQ:SLN) Sees Large Volume Increase - Still a Buy?

July 28, 2026 | marketbeat.com

Silence Therapeutics (NASDAQ:SLN) Reaches New 12-Month High - Time to Buy?

July 23, 2026 | marketbeat.com

Silence Therapeutics (NASDAQ:SLN) Stock Price Up 6.9% - Here's Why

July 22, 2026 | marketbeat.com

Silence Therapeutics (NASDAQ:SLN) Sets New 52-Week High - Here's Why

July 17, 2026 | marketbeat.com

SLN Stock Skyrockets 107% in Six Months: Here's What You Need to Know

July 16, 2026 | zacks.com

Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last?

July 16, 2026 | zacks.com

Silence Therapeutics (NASDAQ:SLN) Shares Up 10% - Here's What Happened

July 15, 2026 | marketbeat.com

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Average Rating of "Moderate Buy" from Brokerages

July 12, 2026 | marketbeat.com

Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy)

July 12, 2026 | seekingalpha.com

Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential

June 30, 2026 | insidermonkey.com

Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?

June 25, 2026 | zacks.com

Silence: 'Buy' Zerlasiran Program Shift And Divesiran Results August 2026

June 12, 2026 | seekingalpha.com

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

June 11, 2026 | businesswire.com

Silence Therapeutics (SLN) Receives a Buy from H.C. Wainwright

May 27, 2026 | theglobeandmail.com

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

May 27, 2026 | businesswire.com

Silence Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SLN

May 18, 2026 | benzinga.com

Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference

May 13, 2026 | pharmiweb.comP

Silence Therapeutics highlights recent business achievements and reports first quarter 2026 financial results

May 7, 2026 | msn.com

Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?

April 16, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

PRTC, ONT, OXB, and SLN Company Descriptions

Montrose Environmental Group NYSE:ONT

$21.03 +0.81 (+4.01%)

As of 07/31/2026 03:58 PM Eastern

Montrose Environmental Group, Inc. operates as an environmental services company in the United States, Canada, and internationally. The company operates in three segments: Assessment, Permitting and Response; Measurement and Analysis; and Remediation and Reuse. The Assessment, Permitting and Response segment provides scientific advisory and consulting services to support environmental assessments; environmental emergency response and recovery; toxicology consulting and environmental audits and permits for current operations; facility upgrades; new projects; decommissioning projects; and development projects. This segment also offers technical advisory and consulting services, including regulatory compliance support and planning, environmental, ecosystem and toxicological assessments, and support during responses to environmental disruptions. The Measurement and Analysis segment tests and analyzes air, water, and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna, and human health. Its services include source and ambient air testing and monitoring, leak detection, and advanced analytical laboratory services, such as storm water, wastewater, and drinking water analysis. The Remediation and Reuse segment provides engineering, design, implementation, and operations and maintenance services primarily to treat contaminated water, remove contaminants from soil, or create biogas from waste. The company serves financial, oil and gas, utilities, construction, automotive, real-estate, midstream energy, manufacturing, commodities, petrochemical, food and beverage, telecommunications, and engineering industries, as well as local, state, provincial, and federal government entities. Montrose Environmental Group, Inc. was founded in 2012 and is headquartered in North Little Rock, Arkansas.

PureTech Health NASDAQ:PRTC

$17.42 0.00 (0.00%)

As of 07/30/2026

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Silence Therapeutics NASDAQ:SLN

$10.49 -1.13 (-9.72%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$10.29 -0.20 (-1.91%)

As of 07/31/2026 07:34 PM Eastern

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver. The company develops Zerlasiran (SLN360), which is in phase 2 clinical trial for cardiovascular disease associated with elevated lipoprotein(a); and Divesiran (SLN124), an siRNA molecule that is in Phase I clinical trials for the treatment of genetic hematological conditions, including polycythemia vera. It is also developing SLN-COMP-1 and SLN-COMP-2 for complement-mediated diseases; and SLN-HAN-1 and SLN-HAN-2. It has collaboration agreements with AstraZeneca PLC to discover, develop, and commercialize siRNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; Hansoh Pharmaceutical Group Company Limited to develop siRNAs; and Mallinckrodt Pharma IP Trading DAC to develop and commercialize RNAi drug targets designed to silence the complement cascade in complement-mediated disorders. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, the United Kingdom.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PRTC, ONT, OXB, and SLN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PRTC, ONT, OXB, and SLN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PRTC, ONT, OXB, and SLN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PRTC, ONT, OXB, and SLN Company Descriptions

Montrose Environmental Group NYSE:ONT

PureTech Health NASDAQ:PRTC

Silence Therapeutics NASDAQ:SLN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PRTC, ONT, OXB, and SLN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PRTC, ONT, OXB, and SLN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PRTC, ONT, OXB, and SLN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PRTC, ONT, OXB, and SLN Company Descriptions

Montrose Environmental Group NYSE:ONT

PureTech Health NASDAQ:PRTC

Silence Therapeutics NASDAQ:SLN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools